Ad is loading...
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
TIGVX
Price
$24.47
Change
-$0.39 (-1.57%)
Updated
Nov 15 closing price
Ad is loading...

RERAX vs TIGVX

Header iconRERAX vs TIGVX Comparison
Open Charts RERAX vs TIGVXBanner chart's image
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
Thornburg International Growth R3
Price$24.47
Change-$0.39 (-1.57%)
VolumeN/A
CapitalizationN/A
RERAX vs TIGVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RERAX vs. TIGVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and TIGVX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. TIGVX (799M). RERAX pays higher dividends than TIGVX: RERAX (0.91) vs TIGVX (0.12). RERAX was incepted earlier than TIGVX: RERAX (22 years) vs TIGVX (17 years). TIGVX is a more actively managed with annual turnover of: 63.54 vs. RERAX (34.00). TIGVX has a lower initial minimum investment than RERAX: TIGVX (0) vs RERAX (250). TIGVX annual gain was more profitable for investors over the last year : 10.53 vs. RERAX (7.63). TIGVX return over 5 years is better than : 11.61 vs. RERAX (3.85).
RERAXTIGVXRERAX / TIGVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years17 years-
Gain YTD3.0523.07599%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets129B799M16,145%
Annual Yield % from dividends0.910.12734%
Returns for 1 year7.6310.5372%
Returns for 3 years-19.45-21.3191%
Returns for 5 years3.8511.6133%
Returns for 10 years15.8926.5760%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics